Drugs & TargetsFree FDA approves moxetumomab pasudotox-tdfk for hairy cell leukemia September 14, 2018Vol.44 No.34
Drugs & TargetsFree Boehringer Ingelheim acquires all ViraTherapeutics shares to develop next-gen viral-based therapies September 14, 2018Vol.44 No.34
Clinical RoundupFree Study details incidence and timing of immunotherapy-related fatalities September 14, 2018Vol.44 No.34
Clinical RoundupFree CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer September 14, 2018Vol.44 No.34
Clinical RoundupFree IMV Inc. and Merck to evaluate DPX-Survivac + Keytruda September 14, 2018Vol.44 No.34
Clinical RoundupFree Clinical trial shows best outcomes to date for older Hodgkin lymphoma patients September 14, 2018Vol.44 No.34
Clinical RoundupFree Children who develop ALL may have dysregulated immune function at birth September 14, 2018Vol.44 No.34
Clinical RoundupFree Drug for pancreatic cancer targets two genes at a time September 14, 2018Vol.44 No.34
FreeFunding Opportunities NCCN-Lilly RFP on quality of care in gastric cancer September 14, 2018Vol.44 No.34
